发明公开
EP1014964A1 MELANINS WITH IMPROVED ABILITY TO INHIBIT HIV REPLICATION
失效
具有改进的HIV REPLICATIONSHEMMENDEN性能黑色素
- 专利标题： MELANINS WITH IMPROVED ABILITY TO INHIBIT HIV REPLICATION
- 专利标题（中）： 具有改进的HIV REPLICATIONSHEMMENDEN性能黑色素
-
申请号： EP98904832.7申请日： 1998-02-04
-
公开(公告)号： EP1014964A1公开(公告)日： 2000-07-05
- 发明人: GARGER, Stephen, J., Jr. , NEIDLEMAN, Saul, L.
- 申请人： Biosource Technologies, Inc.
- 申请人地址： 3333 Vaca Valley Parkway Vacaville, CA 95688 US
- 专利权人： Biosource Technologies, Inc.
- 当前专利权人： Biosource Technologies, Inc.
- 当前专利权人地址： 3333 Vaca Valley Parkway Vacaville, CA 95688 US
- 代理机构： Schüssler, Andrea, Dr.
- 优先权： US796822 19970206
- 国际公布： WO9834606 19980813
- 主分类号： A61K31/195
- IPC分类号： A61K31/195 ; A61K31/40 ; A61K31/785
摘要：
Novel enzymatically produced melanins are described that are useful in the treatment of HIV infection. The novel melanins are optionally modified to contain chemical moieties such as halogens, sulfates, or sulfonyl groups. Additionally, the novel enzymatically synthesized melanins may be modified, or further modified, by chemical oxidation.
信息查询
